BostonGene has entered a new collaboration with AstraZeneca to apply its foundation AI model to oncology drug development, aiming to improve early trial decision-making around safety, efficacy, and ...

New research provides a mechanistic map of how genetic mutations disrupt RNA splicing in acute myeloid leukemia.

Team from Würzburg, Braunschweig, and the US identifies Cas12a3 nuclease showing precise activity | Study just published in Nature ...

Treating acute myeloid leukemia (AML) depends on knowing what goes wrong inside cells. A new study suggests that two genetic ...

Genetic and metabolic differences may increase aggressive early breast cancer risk in Latin American women with obesity, ...

Across all domains of life, immune defenses foil invading viruses by making it impossible for the viruses to replicate. Most ...

Cell division is an essential process for all life on Earth, yet the exact mechanisms by which cells divide during early ...

Sulfolobus islandicus, an archaeal model organism, offers unique advantages for metabolic engineering and synthetic biology ...

To determine who could benefit from targeted cancer treatments, a researcher at the University of Missouri has put tumors under a spotlight.

The ratio between two signaling molecules may be a key marker of MS brain inflammation and help identify candidates for BTK ...

We report the case of a 17-year-old adolescent presenting with a large pineal region mass initially interpreted as a ruptured ...

The nonapeptide Oxytocin is a cyclic nine-amino‐acid peptide that has long been studied for its possible roles in ...